ArticleScientific reports2025
Prophylactic anticoagulation in traumatic subdural hematoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe traumatic brain injury (TBI) with acute subdural hematoma (SDH) is common in neurosurgical care. Especially due to demographic development, it becomes increasingly coincident with preexisting therapeutic anticoagulation and comorbidity, such as atrial fibrillation or coagulative disorders. High-velocity trauma mechanisms become rarer, while low-impact trauma to the skull with acute-on-chronic subdural hemorrhage gets relatively more frequent. In this study we elucidate the timing of perioperative prophylactic AC and its influence on morbidity and mortality as well as complications after neurosurgical treatment. We focused especially on postoperative intracranial hemorrhage (PH) and thromboembolic events (TE). For this retrospective data analysis, 259 patients who suffered from severe TBI with consecutive subdural hematoma between 01/01/2014 and 31/12/2019 were included. We followed up for the length of stay. We assessed various biographical and clinical data for risk factors and focused on the connection between time-point of AC and adverse events. Subgroup analyses were performed for TE and PH that either required surgical intervention or was managed conservatively with radiological follow-up. Statistical analysis was performed using receiver operating characteristic curve analyses, Mann-Whitney U Test, Chi-square test, Fisher's exact test and univariate binomial logistic regression. P-values below 0.05 were considered statistically significant. TE were relatively rare in this cohort (n = 14, 5.4%). The more common adverse event was PH (n = 34, 13.1%), with a total of 28 patients (10.8%) needing surgical revision. Though PH was correlated to a delay in AC (p = 0.010), there was no correlation between early prophylactic AC and PH (p = 0.287) or TE (p = 0.444), respectively. Furthermore, only 4 patients had been administered AC before the PH. In this context, AC was delayed purposely after PH, explaining the significant correlation between PH and delayed AC. Occurrence of PH significantly decreased overall survival (p = 0.022), while TE did not (p = 0.357). Prophylactic AC within 24-48 h after surgery did not result in more frequent PH. Our data on AC timing suggest that PH is not caused by prophylactic AC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.